Carson Wealth (CWM LLC)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9K Sell
658
-1,025
-61% -$25.1K ﹤0.01% 4679
2025
Q4
$45K Buy
1,683
+175
+12% +$4.51K ﹤0.01% 3674
2025
Q3
$40K Sell
1,508
-2,994
-67% -$77.3K ﹤0.01% 3696
2025
Q2
$103K Buy
4,502
+3,834
+574% +$95.1K ﹤0.01% 2690
2025
Q1
$19K Sell
668
-486
-42% -$15.5K ﹤0.01% 3695
2024
Q4
$43K Buy
1,154
+158
+16% +$7.22K ﹤0.01% 2907
2024
Q3
$48K Buy
996
+32
+3% +$1.4K ﹤0.01% 2715
2024
Q2
$39K Buy
964
+218
+29% +$9.03K ﹤0.01% 2629
2024
Q1
$33K Buy
746
+285
+62% +$14.7K ﹤0.01% 2566
2023
Q4
$29K Sell
461
-35
-7% -$1.84K ﹤0.01% 2524
2023
Q3
$23K Sell
496
-15
-3% -$818 ﹤0.01% 2585
2023
Q2
$29K Hold
511
﹤0.01% 2383
2023
Q1
$19K Sell
511
-65
-11% -$2.13K ﹤0.01% 2532
2022
Q4
$16K Sell
576
-1
-0.2% -$29 ﹤0.01% 2497
2022
Q3
$16K Buy
577
+14
+2% +$457 ﹤0.01% 2359
2022
Q2
$20K Buy
563
+34
+6% +$1.21K ﹤0.01% 2097
2022
Q1
$19K Buy
529
+298
+129% +$8.45K ﹤0.01% 2098
2021
Q4
$5K Buy
+231
New +$4.72K ﹤0.01% 2689

Other funds holding AMPH

Carson Wealth (CWM LLC)'s AMPH Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Amphastar Pharmaceuticals (AMPH) stake by 61% in Q1 2026, selling an estimated $25.1K and leaving 658 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4679.

Carson Wealth (CWM LLC) first reported a position in AMPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $103K in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Carson Wealth (CWM LLC) held 658 shares of Amphastar Pharmaceuticals worth $12.9K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 1,025 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $25.1K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4679 holding.
  • Carson Wealth (CWM LLC) first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Amphastar Pharmaceuticals position peaked at $103K in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.